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Experimental and bioinformatic studies of transcription initiation by RNA polymerase II (RNAP2) have
revealed a mechanism of RNAP2 transcription initiation less uniform across gene promoters than initially
thought.However,thegeneraltranscriptionfactorTFIIBispresumedtobeuniversallyrequiredforRNAP2
transcriptioninitiation.BasedonbioinformaticanalysisofdataandeffectsofTFIIBknockdowninprimary
and transformed cell lines on cellular functionality and global gene expression, we report that TFIIB is
dispensablefortranscriptionofmanyhumanpromoters,butisessentialforherpessimplexvirus-1(HSV-1)
gene transcription and replication. We report a novel cell cycle TFIIB regulation and localization of the
acetylated TFIIB variant on the transcriptionally silent mitotic chromatids. Taken together, these results
establishanewparadigmforTFIIBfunctionalityinhumangeneexpression,whichwhendownregulatedhas
potent anti-viral effects.
B
asal transcription factors have been considered to be essential for all RNA polymerase II (RNAP2) pro-
moters. The original set of general transcription factors (TFIID subunit TBP, TFIIB, TFIIA, TFIIF, TFIIE,
TFIIH), identified in studies of a limited set of promoters appears however to be incomplete
1, while at the
sametimecasesofRNAP2transcription thatareindependent ofTBP,TFIIA, TFIIF,TFIIEandTFIIHhavebeen
amplydocumented
2–10.ResultsfromtheEncyclopediaofDNAElements(ENCODE)projectrevealedthatfactors
previously considered specific, such as E2F1, are more prevalent at transcriptional start sites than many of the
original general factors
11,12, blurring the distinction between ‘general’ and ‘specific’ transcription factors.
Supporting the lack of such distinction are cases where a specific factor such as YY1 is needed for basal tran-
scriptionundercertainconditions
9.Correspondingly,statisticalanalysisofcorepromotershasfailedtoidentifya
straightforwardsequencepatternforgenecorepromoters.Instead,numerouscomplexcombinationsofsequence
elements have been identified
1,13, suggesting that the sequence affects the minimal composition of the RNAP2
pre-initiation complex (PIC)
14,15. Moreover, the local structure of the promoter has the potential to affect PIC
composition as well. For example, negative supercoiling of the DNA template can abolish the requirement for
TFIIH
2,8 and TBP
6,16. Presently, all lines of available evidence point to the existence of various RNAP2 PICs,
the composition of which depends on the DNA promoter sequence, its local DNA dynamics
17,18, and cellular
conditions.
Notably, the general factor TFIIB, unlike all other RNAP2 general transcription factors, has never been
reported as dispensable for transcription except in a recent report that demonstrated TFIIB knockdown did
not affect expression of histone genes in Drosophila
19. The role of TFIIB is still poorly understood
20. Besides a
critical role in transcription initiation, it has been proposed that TFIIB may influence start site selection and
transcription termination bybindingto the 39ends ofgenes
21–26.InPICchromatographic separations, this factor
is known to elute separately from the rest of the known PIC components, and its binding to promoter DNA is
weak in the absence of TBP or YY1
9. In the context of the ‘‘classical’’ TATA-box adenovirus major late promoter
(AdMLP), TFIIB is known to bind a pair of TFIIB recognition elements up- and downstream of the TATA box
(BREu and BREd), stabilizing the TBP-TATA box complex and assisting in recruitment of the polymerase to the
precise transcriptional start site (TSS) in vitro
10,27–32. However, little if anything is known about the role of TFIIB
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cells where the large majority of promoters (,90%) are BRE-less/
TATA-less
13.
Whether results derived from studies of RNAP2 transcription
initiation in vitro accurately model the requirements for RNAP2
transcription initiation in vivo, where the DNA is organized as a
chromatin template in the highly dense nuclear environment, has
not been systematically studied. Here we examine the RNAP2 tran-
scription requirements for TFIIB in vivo, by analyzing data from the
Gene Expression Atlas and the Encyclopedia of DNA Elements
(ENCODE) project, by applying TFIIB knockdown in various cell
typesandanalyzing cellulargene microarrays, cellularfunctions, cell
cycletransitions,viralreplicationandviralgeneexpressioninhuman
cells.Theresultsrevealsurprisingdifferencesintherequirementsfor
transcription between cellular and viral promoters and demonstrate
that TFIIB is likely to be dispensable for transcription of many cel-
lular genes. TFIIB however, is essential for HSV transcription and
replication. In addition, we report a novel cell cycle TFIIB regulation
and localization of acetylated TFIIB on the transcriptionally silent
mitotic chromatids.
Results
ENCODE data reveal that overlap of TFIIB binding at TSS with
TFIIF and RNAP2 in the human genome is partial and cell specific.
To define the cistrome of TFIIB, first we analyzed chromatin immu-
noprecipitation-tiling array (ChIP-Chip) data encompassing the
human genome from the ENCODE Project
11. We compared the
distribution of RNAP2 and general transcription factor TFIIB and
TFIIF binding sites, as determined by chromatin immunoprecipi-
tation with antibodies specific to the RNAP2 a-subunit (POLR2A),
TFIIB (GTF2B) and TFIIF (GTF2F1). The ENCODE data is from the
human leukemia cell line K562. Within the 28292 presently known
human genes
33, 11569 bound to RNAP2. Thus, 41% of ENCODE
region genes are actively transcribed by RNAP2 in K562 cells.
Figure 1A shows the total number of sites bound to RNAP2, TFIIF,
and TFIIB, and the fraction proximal (1/2 1000 bp) to ‘‘known
gene’’ transcriptional start sites (TSS). Of the 11569 sites bound to
RNAP2, 5682 mapped to TSS regions. Similarly, 9726 sites bound to
TFIIB were detected, of which only 41% (3964) localized to TSS areas.
Consistent with this, a study of the rat genomereported TFIIB binding
predominantly in regions distinct from the established 59-termini of
proteincodinggenes
34.Additionally,21882sitesboundtoTFIIF,6647
of which were proximal to TSS sequences. As shown in Figure 1B,
82% (4636) of TSS that bound RNAP2 also bound TFIIF. In contrast,
only 60% (3400) of TSS that bound RNAP2 also bound TFIIB.
RNAP2 binding to TSS may reflect RNAP2 at TSS as well as
paused RNAP2 and RNAP2 actively engaged in transcription in
surrounding 1 kb of sequence, which are not expected to contain
TFIIB as it is released from the promoter shortly after the initiation
of transcription. Whereas 90% (3574) of TSS that bound TFIIB also
bound TFIIF, only 53% (3518) of TSS with bound TFIIF also bound
TFIIB.Together,thesedataraisethequestionofwhetherRNAP2may
initiate transcription in the absence of TFIIB on at least some genes,
such as the recently described Drosophila histones
19, under certain
cellular conditions. These data support the paradigm that both
TFIIB and TFIIF may play other roles besides being accessory
proteins for RNAP2 transcription initiation.
We also determined the cistrome of TFIIB in the human promye-
locytic leukemia cell line HL60 after stimulation with retinoic acid
(32 h) to promote differentiation to mature granulocytes. The avail-
ablepilotENCODEChIP-Chipdataencompassing1%ofthehuman
genome
11 (Figure 1C) shows that, of 762 known TSSs, 21% (160)
boundRNAP2within1/21000 bpofflankingsequence.Only6%of
TSScontainedboundTFIIB.Ofthe160 TSSsboundtoRNAP2,only
17% also contained TFIIB within 1/21000 bp. Taken together,
these data raise the possibility of potentially important gene and cell
type differences in TFIIB utilization.
TFIIBexpression varies widely indifferent mammalian cell types.
To further understand transcription factor TFIIB function in cells,
we examined TFIIB availability in different mammalian cell types.
Analyzing the mRNA levels published in the Gene Expression Atlas
and Allen Brain Atlas demonstrated that the ratio of transcripts for
thelargesubunitofRNAP2toTFIIBvariedwidelyfrom2(inhuman
fetal lung) to 32 (in alveolar cell lineRH41) (Supplemental Figure 1).
Although transcript amounts may not reflect protein expression, in
Figure 1 | TFIIB binding sites in relation to RNAP2 and transcriptional start sites. Analysis of ENCODE chromatin immunoprecipitation-tiling
microarray(ChIP-chip)data.(A)TFIIBandRNAP2bindingsiteswithin‘‘KnownGene’’genestartsitesinthehg19humangenomereleasefromhuman
K562 cells and fraction within 1/21 kb of TSS; (B) Overlap between TFIIB-, TFIIF-, and RNAP2-bound sites within 1/21 kb of TSS in K562 cells. (C)
Overlap between TFIIB-, and RNAP2-bound sites within 1/21 kb of TSS in HL60 cells from the hg18 release (D) TFIIB protein immunofluoresence in
mouseblastocyst;TFIIB(green)andDAPI(blue).Theblastocytedomainsareshownonthediagramattheright:redarrow-innercellmass;bluearrow-
outer thin layer.
www.nature.com/scientificreports
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found to vary significantly between cell types during murine
embryogenesis. As shown for a mouse embryo at the blastocyst
stage (Figure 1D), a high level of TFIIB protein was observed in
the inner cell mass forming the embryoblast, whereas TFIIB
protein was undetectable in cells from the outer thin layer
trophoblast, which becomes the placenta. Though it is possible that
TFIIB epitope accessibility may vary by cell type or during mouse
development, a similar variation in TFIIB expression is observed
during Xenopus embryogenesis (Supplemental Figure 2). Further-
more,TFIIBproteinexpressionisinducedintheadultratcentraland
peripheral nervous system upon injury
35–37, decreased in primate
brain after estadiol treatment
38, and markedly up- or down-
regulated by differentiation in some cell types
36,39. These data
prompted us to examine the functional consequences of TFIIB
deficiency on RNAP2 transcription initiation in intact cells.
LossofTFIIBisnotlethalforhumancells.Wecomparedtheeffects
of depleting TFIIB to depletion of transcription factor YY1, a
ubiquitously distributed transcriptional repressor, in several human
cultured cell lines, including HeLa, primary human umbilical vein
endothelial cells (HUVEC) and primary human coronary smooth
muscle cells by siRNA gene knockdown. Achieving transfection
efficiency greater than 95% with two different siRNAs, the level of
TFIIB protein was brought toless than200 molecules per cell by90 h
posttransfection(estimate based onWestern blot, Figure2A, Supple-
mental Figure 3). Such a level of a universally required factor would
be vastly insufficient to sustain cellular transcription from all active
genes. At 72 h (Figure 2) and 96 h (not shown) post siRNA transfec-
tion, all cell types showed viability (Figure 2B), active replication
(Figure 2C) and no detectable TFIIB protein (Figure 2A). As a
control, we knocked down the specific transcription factor YY1,
and tested the effects of transcription factor deficiency on the cells.
The loss of YY1 induced apoptosis in all cell types, while TFIIB
knockdown cells were indistinguishable from cells transfected with
anegativecontrolsiRNA(Figure2B).Thymidineincorporationassay
(Figure 2C) showed that DNA synthesis was significantly more
affected by YY1 (60–80% decrease) than TFIIB knockdown (.10%
decrease) in all cells.
TFIIBdeficiencyproducesspecificalterationsinthehumantrans-
criptome. Changes in cellular transcript levels in TFIIB knockdown
HeLa were analyzed by gene-chip microarray at 90 h post
transfection. Consistent with the observed resilience of the cells to
TFIIB knockdown, only ,1% of the ,33,000 gene probes analyzed
were differentially regulated .2.02-fold in response to TFIIB
knockdown (Figure 3A). The data show 91 up-regulated genes and
150 down-regulated genes. Most of the up- and down-regulated
genes with known promoter sequences have several TFIIB con-
sensus binding sites (BRE) upstream and downstream of the TSS
(Supplemental Figure 4). The BRE free HSP70 promoter con-
firmed to be unaffected. Pathway analysis using the Ingenuity
TM
Knowledge Base clustered the downregulated genes to specific cellu-
lar functions related to viral infectious diseases and cell growth
(Supplemental Figure 5). In addition, members of the integrin
family, actin cytoskeleton, and calcium signaling pathways, includ-
ing several proteins involved in cell adhesion, were dysregulated
more than two-fold (Supplemental Tables S1, S2).
Transcription factors that could substitute for human TFIIB on
certain promoters may exist and remain to be established, but a
universal replacement for TFIIB is unlikely as revealed by some in
vitro transcriptional experiments (data not shown). In yeast, over-
expression of the transcriptional co-activator PC4 homolog protein
hasbeenshowntorescueacold-sensitiveTFIIBmutant
40.According
to the gene microarray data, TFIIB knockdown caused human PC4
up-regulation by 2-fold, the threshold for statistically significant
change in gene expression for this data set. To search for candidate
TFIIB-redundant factors, we mapped the gene expression data onto
the known TFIIB protein binding network, according to the
Ingenuity
TM Database (Figure 3B). Statistically significant changes
in expression were identified by the microarray and RT-PCR
(Figure 3C) for five genes of the TFIIB binding network. A 3-fold
decrease was observed in the transcripts of histone deacetylase
HDAC4, histone H1 variant X, down-regulator of transcription
DR1(NC2),CLOCKhomolog,andcAMP-responsiveelementbind-
ing protein 5. The only up-regulated gene was MTPN, a gene that
encodes myotrophin and leucine zipper protein 6. Nodifference was
observed in the expression of PC4 or histones H2A or H2B. As
expected, the ChIP with TFIIB antibody revealed absence of TFIIB
Figure 2 | Cellular response to TFIIB knockdown in human cells. (A)
TFIIB-siRNA knockdown in HeLa cells 90 h post transfection. TFIIB
protein in cell lysate by Western blot is shown (lane 2); control siRNA
(CsiRNA, lane 1), BsiRNA (lane 2), and transcription factor YY1siRNA
(lane3)areshownforcomparison.Antibodiesareindicatedontheleftand
position of protein markers are on the right. TFIIB knockdown efficiency
was also assessed by immunofluorescence: TFIIB (red), and DAPI (blue).
The unprocessed image is shown in Supplemental Figure 6. (B) Apoptosis
in cells with B-, YY1-, and CsiRNA knockdown. The diagram presents the
% of apoptotic cells from three independent experiments for the indicated
cell types: C - control, B - BsiRNA, YY1 – YY1siRNA. The total amount of
cells is taken as 100%; (C) Thymidine incorporation assay in siRNA-
treatedcells.SeventyhoursaftersiRNAtransfection,cellsweregiven[
3H]-
thymidine for 12 hours: C-control, B- The data were calculated as the
mean plus standard deviation from three experiments in triplicates
BsiRNA, YY1 siRNA.
www.nature.com/scientificreports
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were down-regulated (green) and 91 were up-regulated (red) more than 2-fold (Supplemental Tables 1 and 2) as compared to control transfection. (B)
Protein-protein binding network of TFIIB, according to the Ingenuity
TM Knowledge Base (Ingenuity.com): Genes of proteins interacting with TFIIB
bindingpartnersthatwereup-(red)ordown-(green)regulatedbymorethan2-foldareindicated.Forclarity,onlynodesconnectingtheaffectedgenesto
TFIIB are shown. (C) The mRNA content (in relative units on the vertical) of HDAC4, DR1, CLOCK, H2B, H2A, H1X, PC4, MTPN, TFIIB in TFIIB
deficient cells (red) and wild type cells (blue) was analysed by qRT-PCR. The identity of the gene specific mRNA transcripts is indicated below the bars.
The data were calculated as the mean plus standard deviation from three experiments in triplicates with normalization by 18S rRNA and presented as a
comparison with the cells that received control siRNA. The blue bar represents the cells transfected with control siRNA, and the values have been
normalizedto1.*referstostatisticalsignificance(ttest,P,0.05).(D)ChIPoftheDR1promoterregionandTFIIB-specificantibody(aB)inHeLacells.
Lanes 1 and 3 show amplification of the DR1 promoter fragment before ChIP (total); lane 2- amplification of DR1 promoter fragments captured by the
TFIIB antibody from CsiRNA treated cells; lane 4- amplification from BsiRNA treated cells. Lane 5 shows the captured and PCR amplified CsiRNA
fragments with control pre immune antibody (aX). The unprocessed CHIP image is shown in Supplemental Figure 6. (E) RNA stability in response to
CsiRNA(bluebars)andBsiRNA(redbars)wascomparedinactinomycinDtreatedcells(10 mg/ml).RNAwasisolatedatdifferenttimepoints(min)after
addingactinomycinDasshownbelowthebars.TheisolatedtotalRNA(0.1 mg)wasprobedforH2B,H2A,andPC4mRNAbyRT-PCR.Therelativeunits
values are normalized to 1 (control siRNA values). * refers to statistical significance (t test, P , 0.05).
www.nature.com/scientificreports
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(Figure 3D). Microarray analyses did not reveal significant changes
in the expression of genes involved in global mRNA stability.
Moreover, mRNA levels of H2B, H2A, and PC4 in control siRNA
andTFIIBsiRNAknockdowncellsaftertreatmentwithactinomycin
D showed that TFIIB deficiency does not alter the mRNA stability of
the poly(A)-less H2B and H2A mRNAs or the poly(A) containing
PC4 mRNA (Figure 3E). The data suggest possible effects on chro-
matin remodeling or relief of DR1-mediated repression of transcrip-
tion
41 as two potential mechanisms of coping with TFIIB deficiency.
TFIIB silencing selectively inhibits HSV-1 transcription and viral
plaqueformation.Althoughincelltranscriptionfrommanycellular
promoters appears to be resilient to TFIIB depletion (Figures 3), in
vitro observations by us (not shown) and others
42 show that TFIIB is
an essential factor for several HSV-1 promoters. This difference in
the requirement for TFIIB may enable selective inhibition of viral
transcription, and therefore viral replication, by TFIIB silencing. To
testthisdirectly,weinfectedTFIIBknockdownHeLacellswithHSV-
1
42. Plaque assays of HSV-1 infected cells revealed that viral
replication was reduced .7-fold in the TFIIB knockdown cells
(Figure 4A). To examine the global effect of TFIIB knockdown on
HSV-1 gene transcription we used a HSV-1 viral gene microarray
(Figure 4B). Comparing the gene expression profiles of TFIIB
knockdown and control HeLa cells in three independent array
experiments, we observed that all herpes genes that produced a
consistently readable signal in the microarray were downregulated
1.5 to 10-fold in response to TFIIB knockdown. Results from HSV-1
genemicroarraywereverifiedbyRT-PCRonselectgenes(Figure4C)
Figure 4 | Effect of TFIIB knockdown on viral growth and viral gene
transcription in HeLa cells. (A) HSV-1 plaque assay in TFIIB (B) and
control (C) siRNA knockdown HeLa cells (60 h post transfection). Mean
viral growth (PFU/cell) is indicated (n 5 6). (B) Genomic HSV-1
microarray analysis of viral gene expression in TFIIB knockdown HeLa
cellstransfectedwithsiRNAand60 hlaterinfectedwithHSV-1strainKOS
at 2.5 PFU/cell. RNA was isolated 12 h post infection; control (dark blue
bars) and TFIIB (sky blue). Genes are shown at right. (C) RT-PCR of the
HSV-1 genes ICP0, ICP22, ICP4 in infected HeLa cells 12 h post infection
relative to ARPP0 mRNA from negative control transfection. C-control
siRNA knockdown cells; B- TFIIB knockdown cells. Results were
consistent in four independent experiments. (D). The TFIIB and ICP4
immunofluorescence in virus-infected cells. Cells received either TFIIB or
control siRNA and were stained with (a, d) anti-TFIIB antibody (green),
(b, e) anti-ICP4 antibody (red) or (c, f) DNA with DAPI (blue).
Figure 5 | Functions of TFIIB and the acetylated TFIIB variant in cell
cycle transitions. (A) TFIIB immunofluorescence (red) after release from
nocodazole block (hours). DNA is stained with DAPI (blue). (B) DAPI
flow cytometry of control siRNA (wt) or TFIIB siRNA (2B) treated cells
after release from nocodazole block (hours). DNA content is shown below
(2N,4N).(C) Confocalmicroscopy ofnonacetylated andacetylated TFIIB
in HeLa cells visualized with nonacetylated TFIIB specific (aB) or acetyl-
TFIIB(aAcB)specificantibodiesbyimmunofluorescence(red)withDAPI
staining (blue) during the indicated above the plots cell cycle phase. (D) A
westernblot(left)showsthattheTFIIBantibody(aB)inamixturewiththe
12 amino acids acetyl Lysine TFIIB peptide (acp) recognises only the
nonacetylated recombinant TFIIB (rhnB, lane 1) and not acetylated
recombinant TFIIB (rhacB, lane 2). The anti acetyl-TFIIB andibody (acB)
(rightblot)recognisestheacetylatedrecombinantprotein(lane4)andnot
the nonacetylated TFIIB protein (lane 3). Ponceau S (S) staining of each
blot before immunostainning is shown beneath the respective westerns.
The unprocessed images are shown in Supplemental Figure 6.
www.nature.com/scientificreports
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immunofluorescence (Figure 4D). Consistent with our unpu-
blished in vitro experiments, the HSV-1 gene array and RT-PCR
experiments (Figure 4B) revealed that the viral TK (UL23) pro-
moter was repressed more than 5 times in the absence of TFIIB. In
contrast, the immediate early gene promoter ICP0 remained
unperturbed at 3 hours post infection (Figure 4C), the time of peak
activity during normal viral infection
42. The ICP4 gene, which
requires TFIIB in vitro (not shown) is essential for viral replica-
tion
42. In addition to its role in basal transcription, TFIIB mediates
HSV-1 transcriptional activation via interactions with the HSV
proteins VP16 and ICP4
42, a mechanism of regulation presumably
sharedamongthemajorityofherpesgenes
42.TFIIBknockdownmay
thus have a doubly inhibitory effect on herpes viral transcription in
cells.
InadditiontothedirecteffectsofTFIIBonHSV-1genetranscrip-
tion, transactivation
42, and replication, TFIIB may indirectly affect
viral gene expression and growth via alterations in the cellular tran-
scriptome. Supporting this idea, an analysis of the changes in the
human transcriptome in the absence of TFIIB using the Ingenuity
TM
Knowledge Base predicted inhibition of replication across a broad
range of viral taxa, with the utmost statistical significance (Supple-
mental Figure 5a).
TFIIBexpressionandacetylationisgovernedbythecellcycle.Vir-
uses commonly arrest cell cycle progression to facilitate replication,
in part via cyclins and their interaction partners. TFIIB has high
structure and sequence similarity to cyclin A
31. Like the cyclins,
TFIIB knockdown is not lethal to the cells
43,44. Whether TFIIB also
hascellcyclephase-specificregulationandfunctionalitylikecyclinA
has not previously been explored. The experimental evidence we
present here suggests that like the cyclins, the expression of TFIIB
oscillates during the cell cycle in proliferating cells. In cultured HeLa
cells released from nocodozole arrest, total TFIIB expression is
elevated when a majority of cells are in the S phase and lowered as
the cells progress to the G2 and M phase (Figure 5A).
FACS analyses of cells synchronized with nocodozole revealed
thatTFIIBknockdownalteredthecellcyclebydelayingtheexitfrom
G2/M and progression to S phase (Figure 5B) suggesting yet another
similarity to cyclin A, which is required for entry into M and the
completion of S
43,44.
We have previously reported that TFIIB is an autoacetylase
45.
Protein acetylation plays a key role in mitotic progression
46.T o
determine whether TFIIB is acetylated in a cell cycle phase-specific
manner, we examined the subcellular distribution of non-acetylated
and acetylated TFIIB during the cell cycle and mitosis by confocal
microscopy (Figure 5C), using antibodies specific for each variant
(Figure 5D). Non-acetylated TFIIB colocalized with DNA in the G0/
1, S, and G2 phases of cell cycle, but not during mitosis, consistent
withstudiesshowingGFP-taggedTFIIBisnotboundtoDNAduring
mitosis
47. In contrast, the acetylated TFIIB variant colocalized to
DNA during mitosis at prophase, metaphase, anaphase, and telo-
phaseinaddition totheother phasesofthecellcycle,consistentwith
detectionofTFIIBboundtothetranscriptionallysilentmitoticDNA
by more sensitive ChIP analysis
48.
The presence of the acetylated TFIIB variant during the different
states of mitosis when RNAP2 ceases active transcription raises the
questionofitsfunctionalmeaning. AcetylatedTFIIBcouldserveasa
‘‘memory (epigenetic) imprint’’ for RNAP2 recruitment and bulk
RNAsynthesisofspecificgenesatthemitoticexit,fortranscriptional
reactivation of the genome. The exact function of the acetylated
TFIIB variant during mitosis and the mitotic exit remains to be
established. Nevertheless, the TFIIB function with its autocatalytic
acetylation activity adds a new metabolic aspect to the elaborate cell
cycle control system.
Discussion
ThegeneraltranscriptionfactorTFIIBiswidelyreportedasanessen-
tial component for transcription initiation by RNA polymerase II,
although RNAP2 transcription initiation independent of general
transcription factors TBP, TFIIA, TFIIF, TFIIE and TFIIH is well
reported
2–10.OurdatashowthatknockdownofTFIIBinhumancells
doesnotaffectcellviability,DNAsynthesis,oryield$2-foldchanges
inexpressionofmost human genesineitherprimaryortransformed
celllines.Thoughwecannot exclude thatTFIIBknockdown globally
affects mRNA stability, TFIIB knockdown in the presence of actino-
mycin D did not alter levels of either total RNA (not shown) or
poly(A) and poly(A)-less mRNAs of select genes. Together, these
data suggest that TFIIB is dispensable for in vivo RNAP2 transcrip-
tion initiation on most human genes. In agreement with this, pre-
vious reports of TFIIB knockdown in trypanosome, Drosophila, and
mammaliancelllinesdidnotreportanimpactofcellviabilityorlarge
changes in expression of the few genes examined
19,36,49. This is con-
sistent with the viability of transgenic mice expressing mutant poly-
glutamine tract-expanded TBP, which causes low TFIIB occupancy
oftheHSPB1promoter
50andpresumablythoseofothergenes,butin
contrast to early RNAP2 in vitro studies which established the min-
imal requirements for RNAP2 transcription
51.
In contrast to human gene transcription, we found TFIIB is
required for transcription of HSV-1 genes as well as HSV-1 viral
replication. The disparity between TFIIB requirements in human
and herpesviral transcription may reflect differences in promoter
organization,TFIIBautoacetylation
45,and/orsecondaryinteractions
between TFIIB with human or viral transcription machinery
20 and/
or chromatin components
52. Moreover, TFIIB may have indirect
effects on viral replication via alterations in the human transcrip-
tome. Indeed, in cells subjected to TFIIB knockdown, Ingenuity
TM
Pathway Analysis predicts impaired replication of a wide range of
viruses. Taken together with previous studies showing transcription
factors from multiple viruses complex with TFIIB to transactivate
viraltranscription, ourdatasuggestthatblockadeofTFIIBmayhave
broad anti-viral effects.
OurdatasupporttheideathatcellularTFIIBexpressionisdynam-
ically regulated. TFIIB expression changes in a cell cycle dependent
manner and, relative to that of RNAP2, varies widely between cell
types. Of note, TFIIB promotes certain transcriptome changes that
drive cellgrowth and cellcycle progression. Consistent with this, cell
differentiation markedly downregulates TFIIB expression
39 and
TFIIB-homolog depletion decreases growth rate in a trypanosome-
derivedcellline
49.Similarly, this effectmayalsounderlie therecently
described association between TFIIB overexpression and tissue
regeneration
36, human hepatocellular carcinogenesis
53, and the
essential role of TFIIB in specific cases of viral transcription. In
contrast, TFIIB expression also increases during Muller glia cell dif-
ferentiation in vitro, whereas TFIIB knockdown decreased express-
ion of proliferation and differentiation markers, suggesting that the
impactsofTFIIBoncellgrowthmaybecellspecific,contextdepend-
ent,andcomplex
36.Indeed,whileTFIIBmaynotbenecessaryforcell
viabilityandproliferationinhighereukaryotes,itmayberequiredfor
cell differentiation, dedifferentiation, and/or development.
Both archaeabacteria and plants contain multiple copies of TFIIB
homologs
54,55. In archaeabacteria, individual isoforms of the TFIIB
homolog TFB coordinate discrete environment-specific gene regula-
tory programs
54. These data, together with our own suggest that
TFIIB is likely to be a tissue and cell type specific determinant of cell
growth via its effects on the cellular transcriptome. In addition,
viruses may have evolved a dependence on TFIIB as a ‘‘sensor’’ of
cellular resources to support viral growth and replication, a notion
that remains to be established. In yeast, TFIIB is thought to be essen-
tial for cell viability, and a recent genome-wide analysis revealed
TFIIB crosslinking to TSSs of a vast majority of transcriptionally
active genes
56. As previous work on yeast and archaeal homologs of
www.nature.com/scientificreports
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future studies are needed to address whether the yeast or archaea-
bacterial TFIIB homologs affects cell viabilityor only cell growth, and
whether TFIIB utilization in these organisms is environment-specific.
OurdataalsosupportaroleofTFIIBinregulatinggeneexpression
beyonditsclassicallyrecognizedfunctionwithinthePIC.Analysisof
ENCODE Project ChIP-Chip data encompassing the human gen-
ome
11 revealed 59% of TFIIB bound outside TSS areas, consistent
with previous findings in the rat genome that showed TFIIB binding
wasnotrestrictedtopromoterregions
34andinyeastandhumancells
that TFIIB localized to the 39 end of genes
21–23. Taken together, these
datasuggestthatTFIIBhasfunctionsbeyondtranscriptioninitiation
and apart from the TTS. In support of this, recent work shows TFIIB
localization to the 39 ends of genes links transcription initiation and
terminationviageneloopingorpromotestranscriptionofanti-sense
RNA initiating from the 39 end of genes
21–26. Indeed, targeting of
yeast chromatin remodeling enzyme Isw2 to chromatin was recently
reported to be mediated in part by TFIIB dependent DNA looping
57.
Moreover, our data reveal that acetylated TFIIB is bound to mitotic
chromosomes, when transcription ceases and that TFIIB loss alters
the exit from G2/M and progression to S phase, suggesting TFIIB
may have functions beyond its classical role in gene expression.
The presented data, taken together with recent work from others,
constitutes a fundamental paradigm shift in the understanding of
TFIIB functionality in gene expression. While the precise functions
of TFIIB in cellular gene expression remain to be established, our
findings support the concept that the composition of the PIC is
variable, and likely reflects promoter sequence specific DNA
dynamics and availability of factors that can bind to and regulate
the promoter
1,14,15,58. Factor availability may be regulated by cell-
environment interactions, including metabolism. The acetylation
of TFIIB may be a new regulatory pathway in chromatin regulation
and DNA replication. Uncovering cell cycle-specific functions of the
TFIIBautoacetylatase reveals new aspects of mechanistic integration
of RNAP2 transcription machinery with DNA replication, the cell
cycle, and metabolism. The implications of such connections would
be far-reaching in cellular biology. The territories or chromosomal
compartments that are maintained by the acetylated TFIIB variant
may orchestrate coordinated entry into the next phase of the cell
cycle and remain to be discovered.
Methods
Cellular TFIIB and YY1 knockdown. TFIIB knockdown in HeLa cells was
accomplished by electroporation with the siRNA-specific reagent (MediMAbs) of
endotoxin treated (DETOX, MediMabs, Canada) 1 nmol TFIIB-specific siRNA mix
(Invitrogen) per 10
6 cells or YY1-specific siRNA (Invitrogen) and SilencerH negative
control siRNA (Ambion) as previously reported
45. All transfections are performed
with the siRNA specific reagent TRANS siRNA(MMM-103, MediMabs, Canada).
siRNA is purified from endotoxin contaminations with the DETOS reagent (MMM-
104, MediMAbs, Canada).
Apoptosis, RNA stability assays, and ChIP. Apoptotic cells were identified by
incubationwith5 mMpropidium iodide,followedbyfluorescencemicroscopywitha
TexasRedemissionfilter(632 nm)todetectnuclearstaining.ThemRNAstabilityfor
some genes that did not change level of expression in response to TFIIB deficiency
was identified by treating the cells with actinomycin D (10 mg/ml). Total RNA was
isolated fromcells atdifferent time points. Content of specific mRNAs wasmeasured
by RT-PCR. ChIP with anti TFIIB antibody was conducted as we previously
reported
49. The ChIP primers for the human DP1 encompass 704 bp including
100 bpdownstreamoftheTSS:plusprimer59-TCCTACTTAGCCATTAGGCGAC-
39; minus primer 59-CCAGATGCCAGGGAAGGTTT-39.
Cellular and viral microarrays analysis. Total RNA isolated from HeLa cells 80 h
post transfection with TFIIB-specific or SilencerH negative control siRNA were
analyzed. Two identical microarrays (Agilent Whole Human Genome Oligo
Microarray Kit) were used to compare the two pools. RNA was quantified and the
qualityofthesampleswasexamined usingRNA6000NanoLabChipHKitonAgilent
2100 Bioanalyzer. Cyanine 3- or 5-labeled CTP (10.0 mM) were purchased from
Perkin–Elmer/NEN Life Science. Fluorescently labeled cRNA targets were generated
from 500 ng of total RNA for each reaction using the Agilent Fluorescent Linear
Amplification Kit. Each RNA mix was labeled with both cyanine 3 and cyanine 5 to
allow dye reversal experiments and minimize dye bias. Hybridization was performed
using the Agilent’s in situ Hybridization Plus kit with 1 mg labeled cRNA. The arrays
were scanned using the Agilent dual-laser DNA microarray scanner and data were
extractedwithFeatureExtraction9.1.TheGeneSpringsoftware(Agilent)wasusedto
generate lists of selected genes and for different statistical and visualization methods.
Lowessnormalizationwasappliedtocorrectforartifactscaused bynonlinear rates of
dye incorporation as well as inconsistencies of the relative fluorescence intensity
betweensomeredandgreendyes.Listsofdifferentiallyexpressedgenesconsideringa
2-fold expression cutoff weregenerated by filtering onexpression levelusing the data
fromallindependentexperimentsforeachcondition.Thegenesinthegenelistswere
classified according to their function using the Gene Ontology (GO SLIMS)
classification system. The accession code of the array data is GSE48847.
A microarray (SABiosciences, Frederick, MD) printed with all HSV ORFs and its
application to compare viral genes levels in siRNA treated cells was previously
described in detail
59–61. The data were analyzed with GEArray Expression Analysis
Suite 2.0. Arrays were standardized by using the interquartile method, and the data
are presented as the fold change in expression of heat-shocked versus mock heat-
shocked control. The data represent the averages of three independent experiments.
Infection with HSV-1. HeLa cells were infected with the wild-type virus HSV-1
strain KOS at passage 13 that was propagated as described previously
59.
RT-PCR. The ICP0, ICP4, ICP22 primers for the RT-PCR have been published
elsewhere
59–61.Thefollowingprimershavebeenusedtoassesstheexpressionofgenes
in TFIIB deficient and control HeLa cells: H2A (NM_003528) forward (f)
atgtctggacgtggccaagca, reverse (r) agcttgttgagctcctcgtg; histone H2B/j (AF531291)
f - ccgaagaagggctccaagaa, r - ttatttggagctggtgtacttg; clock f-gcaaaatgtcatgagcacttaatg,
r - ctgcagcccctgaccatggacc; CREB5 (NM 001011666) f- aggtctgggtgatgtcattg,
r - atggctgttattgggcagtc; HDAC4 f- aatctgaaccactgcatttcca, r- ggtggttataggaggtcgacact;
protocadherin 9 (PCDH9) f –acagccaccacggtcctcta, r – cccttgttgttcccgctcac; GTF2B
f-ctggaggagcccccatc, r- cagcaatatctccaatctctttttg; histone H1X (BC000426)
f-gatctacaccgaggccaaga, r-cttcttgcggttgagcttg; PC4 (NM_ 006713.3)
f- tcaagctcttctggcagtga, r - atctctgctgctgctgctct. Three sets of control siRNA and
BsiRNA isolations were assayed in triplicates. Relative gene expression values were
calculated after normalization to 18S rRNA that did not change significantly in
response to siRNA treatment, and adjust the value of the control siRNA sample as 1.
Results obtained in individual experiments were expressed as mean 6 SEM.
Immunofluorescence and Western blotting. The nocodazole-synchronized and
serum stimulated cells were stained with rabbit anti-acetylTFIIB antibody (Abcam)
or with anti-nonacetylated TFIIB and Cy3-labeled secondary antibody. The
polyclonal TFIIB antibody was pre incubated with the acetylated TFIIB peptide
(Abcam). Such treatment resulted in specific recognition of the nonacetylated TFIIB
eliminatingcrossreactivitywiththeacetylatedTFIIB(Figure5C).ICP4wasvisualized
with HSV-1 ICP4 (H943) antibody (Santa Cruz) and YY was visualized with YY1-
MM-0205-P chicken antibody (MediMabs, Canada).
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